Triple

T16946220
Position Surface form Disambiguated ID Type / Status
Subject Sovaldi E411074 entity
Predicate contraindicatedWith P23156 FINISHED
Object amiodarone (relative contraindication due to bradycardia risk)
Amiodarone is a potent class III antiarrhythmic medication used to treat serious ventricular and supraventricular arrhythmias, notable for its complex pharmacokinetics and risk of multiple organ toxicities.
 E1242137 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: amiodarone (relative contraindication due to bradycardia risk) | Statement: [Sovaldi, contraindicatedWith, amiodarone (relative contraindication due to bradycardia risk)]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: amiodarone (relative contraindication due to bradycardia risk)
Context triple: [Sovaldi, contraindicatedWith, amiodarone (relative contraindication due to bradycardia risk)]
  • A. RE-LY trial
    The RE-LY trial was a large, pivotal clinical study that compared the efficacy and safety of the oral anticoagulant dabigatran with warfarin for stroke prevention in patients with atrial fibrillation.
  • B. Entresto
    Entresto is a prescription heart failure medication that combines sacubitril and valsartan to reduce the risk of cardiovascular death and hospitalization.
  • C. Verapaz
    Verapaz is a historical region in Guatemala known for its highland terrain, indigenous Maya communities, and colonial-era missionary history.
  • D. Brilinta
    Brilinta is a prescription antiplatelet medication (ticagrelor) used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with acute coronary syndrome or a history of myocardial infarction.
  • E. Aritimi
    Aritimi is an Etruscan goddess associated with the wilderness, hunting, and the moon, closely related to the Greek Artemis.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: amiodarone (relative contraindication due to bradycardia risk)
Triple: [Sovaldi, contraindicatedWith, amiodarone (relative contraindication due to bradycardia risk)]
Generated description
Amiodarone is a potent class III antiarrhythmic medication used to treat serious ventricular and supraventricular arrhythmias, notable for its complex pharmacokinetics and risk of multiple organ toxicities.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: amiodarone (relative contraindication due to bradycardia risk)
Target entity description: Amiodarone is a potent class III antiarrhythmic medication used to treat serious ventricular and supraventricular arrhythmias, notable for its complex pharmacokinetics and risk of multiple organ toxicities.
  • A. RE-LY trial
    The RE-LY trial was a large, pivotal clinical study that compared the efficacy and safety of the oral anticoagulant dabigatran with warfarin for stroke prevention in patients with atrial fibrillation.
  • B. Entresto
    Entresto is a prescription heart failure medication that combines sacubitril and valsartan to reduce the risk of cardiovascular death and hospitalization.
  • C. Verapaz
    Verapaz is a historical region in Guatemala known for its highland terrain, indigenous Maya communities, and colonial-era missionary history.
  • D. Brilinta
    Brilinta is a prescription antiplatelet medication (ticagrelor) used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with acute coronary syndrome or a history of myocardial infarction.
  • E. Aritimi
    Aritimi is an Etruscan goddess associated with the wilderness, hunting, and the moon, closely related to the Greek Artemis.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d886c886688190967be07322597ac9 completed April 10, 2026, 5:12 a.m.
NER Named-entity recognition batch_69e3cfb25e0c8190948e62d9575ae9cd completed April 18, 2026, 6:38 p.m.
NED1 Entity disambiguation (via context triple) batch_6a00cfeca4208190a3b9270869063d3d completed May 10, 2026, 6:35 p.m.
NEDg Description generation batch_6a00d0b13f1c819091f3f8b966e36214 completed May 10, 2026, 6:38 p.m.
NED2 Entity disambiguation (via description) batch_6a00d1ad6b7081908be76d70ad9e2075 completed May 10, 2026, 6:42 p.m.
Created at: April 10, 2026, 5:31 a.m.